Hatemi, G. Et Al. 2020. Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , vol.18 , 20-21.

Hatemi, G., Mahr, A., Takeno, M., Kim, D., Saadoun, D., Direskeneli, H., ... Cheng, S.(2020). Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , vol.18, 20-21.

Hatemi, Guelen Et Al. "Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study," JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , vol.18, 20-21, 2020

Hatemi, Guelen Et Al. "Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study." JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , vol.18, pp.20-21, 2020

Hatemi, G. Et Al. (2020) . "Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study." JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , vol.18, pp.20-21.

@article{article, author={Guelen Hatemi Et Al. }, title={Efficacy of Apremilast for Oral Ulcers Associated With Active Behcet's Syndrome Over 64 Weeks: Results From A Phase III Study}, journal={JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT}, year=2020, pages={20-21} }